FDA-approved indications for new anticoagulants.
| Anticoagulant . | FDA-Approved Indication for Use . |
|---|---|
| Fondaparinux (Arixtra) | Prophylaxis of venous thromboembolism in hip fracture, hip replacement, knee replacement |
| Lepirudin (Refludan) | Heparin induced thrombocytopenia (HIT) |
| Argatroban | HIT |
| HIT with percutaneous coronary angioplasty | |
| Bivalirudin (Angiomax) | Percutaneous coronary angioplasty |
| Anticoagulant . | FDA-Approved Indication for Use . |
|---|---|
| Fondaparinux (Arixtra) | Prophylaxis of venous thromboembolism in hip fracture, hip replacement, knee replacement |
| Lepirudin (Refludan) | Heparin induced thrombocytopenia (HIT) |
| Argatroban | HIT |
| HIT with percutaneous coronary angioplasty | |
| Bivalirudin (Angiomax) | Percutaneous coronary angioplasty |